Brain Health Films - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Brain Health Films - Licensing Opportunity from Trinity College Dublin - July 2015

Currently there are 150 million Europeans aged over 50. Population ageing is forecast to attain unprecedented levels in Europe over the next 50 years. The term “Silver Tsunami” has been used to describe the potential imp...

pdf 936.1KB

Age Related Macular Degeneration - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Age Related Macular Degeneration - Licensing Opportunity from Trinity College Dublin - July 2015

Age-related-macular-degeneration (AMD) is the leading cause of central vision loss worldwide. Drusen accumulation is the major pathological hallmark common to both dry and wet AMD. While activation of the immune system h...

pdf 997.9KB

Novel Vaccine Components for Whooping Cough - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Novel Vaccine Components for Whooping Cough - Licensing Opportunity from Trinity College Dublin - July 2015

Novel Toll-like receptor 2 (“TLR2”) agonists endogenously derived from Bordetella pertussis, have been discovered and have considerable potential for the development of a more effective vaccine capable of generating prot...

pdf 1.2MB

Cartilage Repair Therapy - Licensing Opportunity from Trinity College Dublin - July 2015 front page preview

Cartilage Repair Therapy - Licensing Opportunity from Trinity College Dublin - July 2015

Articular cartilage injury or degeneration is a common disorder of joints, affecting people of all ages. More than 500,000 cartilage repair procedures are performed annually in the United States alone. The intrinsic rang...

pdf 1.1MB

Novel Biomarker for Multiple Myeloma Diagnosis and Prognosis - Licensing Opportunity from National University of Ireland Galway - March 2015 front page preview

Novel Biomarker for Multiple Myeloma Diagnosis and Prognosis - Licensing Opportunity from National University of Ireland Galway - March 2015

Multiple Myeloma is a highly prevalent disease accounting for 1-2% of all cancers, with a market size for treatments estimated to grow to $7 billion by 2020. This technology will prove to be extremely valuable in fightin...

pdf 1.2MB